JY
FBRX icon

Jeff Yass’s Forte Biosciences FBRX Stock Holding History

Jeff Yass’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Sell
13,800
-20,600
-60% -$488K ﹤0.01% 11090
2026
Q1 		$891K Buy
+34,400
New +$991K ﹤0.01% 8189
2022
Q1 		– Sell
-2,176
Closed -$116K – 13255
2021
Q4 		$116K Sell
2,176
-196
-8% -$13.2K ﹤0.01% 12028
2021
Q3 		$176K Buy
+2,372
New +$1.31M ﹤0.01% 11628
2020
Q3 		– Sell
-824
Closed -$300K – 10691
2020
Q2 		$300K Buy
824
+724
+724% +$324K ﹤0.01% 8366
2020
Q1 		$46K Buy
+100
New +$39.1K ﹤0.01% 9712
2019
Q4 		– Sell
-410
Closed -$102K – 9945
2019
Q3 		$102K Buy
410
+219
+115% +$332K ﹤0.01% 9547
2019
Q2 		$479K Buy
191
+70
+58% +$208K ﹤0.01% 7358
2019
Q1 		$495K Buy
121
+19
+19% +$73.4K ﹤0.01% 6299
2018
Q4 		$315K Buy
102
+28
+38% +$121K ﹤0.01% 6902
2018
Q3 		$435K Sell
74
-113
-60% -$430K ﹤0.01% 6792
2018
Q2 		$655K Buy
187
+76
+68% +$278K ﹤0.01% 6270
2018
Q1 		$493K Buy
111
+25
+29% +$116K ﹤0.01% 6665
2017
Q4 		$331K Buy
+86
New +$343K ﹤0.01% 7425

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jeff Yass's FBRX Position: Q2 2026 in Review

Jeff Yass reduced its Forte Biosciences (FBRX) stake by 89% in Q2 2026, selling an estimated $2.83M and leaving 14,311 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #11016.

Jeff Yass first reported a position in FBRX in Q1 2018 and has held it in 18 quarters since. The position peaked at $3.46M in Q1 2026. 85 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Jeff Yass held 14,311 shares of Forte Biosciences worth $304K as of Q2 2026.
  • Jeff Yass sold 119,183 Forte Biosciences shares in Q2 2026, an estimated $2.83M.
  • Forte Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11016 holding.
  • Jeff Yass first reported a position in Forte Biosciences in Q1 2018 and has held it in 18 quarters since.
  • Jeff Yass's Forte Biosciences position peaked at $3.46M in Q1 2026.
  • 85 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.